SMMT Summit Therapeutics Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Summit Therapeutics (SMMT) Stock: Buy, Sell, or Hold?

$16.64
-1.19 (-6.67%) â–ŧ
5d: +2.91% 30d: +7.22% 90d: +18.86%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
42/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$15.06 – $17.16
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-21.6x
Next 12M consensus est.
Wall Street Target
$29.73
+78.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$14.17 / $18.15
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: SMMT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 6, 2026 at $16.00 · last confirmed Nov 10, 2026

Strength: 6.2/10

Get Alerted When SMMT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: SMMT is currently trading at $16.64, which is considered slightly high relative to its 30-day fair value range of $15.06 to $17.16.

Technical Outlook: Technically, SMMT is in a strong uptrend. Immediate support is located at $14.17, while resistance sits at $18.15. Short-term momentum is weak, with the stock down 6.7% recently.

Market Sentiment: SMMT scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $29.73 (+78.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $15.06 - $17.16
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 36.8%

Trading Range & Key Levels

30-Day Trading Range $15.06 - $17.16
Current vs Trading Range SLIGHTLY HIGH
Support Level $14.17
Resistance Level $18.15
Current Trend Strong Uptrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BEARISH: Weak technical setup (20/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.7%)
  • BULLISH: Trading 78.6% below Wall St target ($29.73)
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -21.56
Wall Street Target $29.73 (+78.6%)
Revenue Growth (YoY) -100.0%
Share SMMT Analysis

Share this live SMMT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (SMMT)

Bullish 3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate bullish sentiment towards $SMMT with no new information from Yahoo Finance news.
Key Retail Themes: Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:17 AM ET
Data refreshes hourly during market hours. Next update: 2:17 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SMMT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 53 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 41 HOLD
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$32 51 HOLD
GPCR
Structure Therapeutics Iâ€Ļ
STRONG BUY
16 analysts
$107 50 HOLD
SNDX
Syndax Pharmaceuticals Iâ€Ļ
STRONG BUY
12 analysts
$35 60 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SMMT Research Pages
SMMT Technical Chart SMMT Price Prediction SMMT Intrinsic Value DCF SMMT Earnings Date Why is SMMT Moving Today? SMMT Investment Advisor SMMT Fair Price Analyzer SMMT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals